Palisade Bio, Inc.

6.97 USD
+0.61 (+9.59%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Palisade Bio, Inc. stock is up 37.48% since 30 days ago. The next earnings date is Aug 9, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 17 May’s closed higher than April. 100% of analysts rate it a buy.

About Palisade Bio, Inc.

Palisade Bio, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract. The company was founded in 2005 and is based in Carlsbad, California.